Consistent with the effect of eIF4E on cell proliferation, we found that silencing eIF4E also enhanced the capacity of ATRA or ATPR to induce AML cell differentiation, characterized by a further elevation in CD11b-positive cell ratio and morphological maturity. Here, EIF4E is linked to acute myeloid leukemia.